Evidence map›Paper›PMID 39664766›Full record

ReviewJB & JS open access

Number of Doses of Systemic Antibiotic Prophylaxis May Be Reduced in Cemented Primary Knee Arthroplasty Irrespective of Use of Antibiotic in the Cement: A Multiregistry-Based Meta-Analysis.

Tesfaye H Leta, Richard N Chang, Anne Marie Fenstad, Stein Atle Lie, Stein Håkon L Lygre, Martin Lindberg-Larsen, Alma B Pedersen, Olav Lutro, Jinny Willis, Chris Frampton and 11 more

Abstract readReview
In one paragraph

Review in JB & JS open access. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Tesfaye H LetaThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.ORCID https://orcid.org/0000-0002-9596-507X
Richard N ChangMedical Device Surveillance & Assessment, Kaiser Permanente, San Diego.ORCID https://orcid.org/0000-0003-2877-8562
Anne Marie FenstadThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.ORCID https://orcid.org/0000-0002-6429-0153
Stein Atle LieThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.ORCID https://orcid.org/0000-0003-4374-9276
Stein Håkon L LygreThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.ORCID https://orcid.org/0000-0001-9146-4510
Martin Lindberg-LarsenThe Danish Knee Arthroplasty Register, Odense, Denmark.ORCID https://orcid.org/0000-0002-4483-677X
Alma B PedersenThe Danish Knee Arthroplasty Register, Odense, Denmark.ORCID https://orcid.org/0000-0002-3288-9401
Olav LutroDepartment of Medicine, Stavanger University Hospital, Stavanger, Norway.ORCID https://orcid.org/0000-0003-3312-3712
Jinny WillisThe New Zealand Joint Registry, Christchurch, New Zealand.ORCID https://orcid.org/0000-0001-7215-0655
Chris FramptonThe New Zealand Joint Registry, Christchurch, New Zealand.ORCID https://orcid.org/0000-0003-0603-5661
Michael WyattThe New Zealand Joint Registry, Christchurch, New Zealand.ORCID https://orcid.org/0000-0001-5283-2608
Serban DragosloveanuRomanian Arthroplasty Registry, Bucharest, Romania.ORCID https://orcid.org/0000-0001-7403-1684
Andreea E VorovenciRomanian Arthroplasty Registry, Bucharest, Romania.ORCID https://orcid.org/0009-0002-3861-2726
Dan DragomirescuRomanian Arthroplasty Registry, Bucharest, Romania.ORCID https://orcid.org/0009-0000-8933-3159
Håvard DaleThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.ORCID https://orcid.org/0000-0002-2962-2706
Geir HallanThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.
Jan-Erik GjertsenThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.ORCID https://orcid.org/0000-0002-8490-268X
Heather A PrenticeMedical Device Surveillance & Assessment, Kaiser Permanente, San Diego.ORCID https://orcid.org/0000-0002-2200-6564
Ove FurnesThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.
Art SedrakyanDepartment of Population Health Science, Weill Medical College of Cornell University, New York.
Elizabeth W PaxtonMedical Device Surveillance & Assessment, Kaiser Permanente, San Diego.ORCID https://orcid.org/0000-0001-8223-2515

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The use of systemic antibiotic prophylaxis (SAP) and antibiotic-loaded bone cement (ALBC) is the accepted practice to reduce the risk of periprosthetic joint infection (PJI) in primary total knee arthroplasty (pTKA). However, practice varies internationally. This study's primary aim was to compare the risk of PJI revision after pTKA with ALBC + SAP vs. plain bone cement (PBC) + SAP, and the secondary aim was to assess whether the risk of PJI revision varies with the number of SAP doses. Methods: Cohort of 289,926 pTKAs for osteoarthritis from arthroplasty registries in Denmark, New Zealand, Norway, Romania, and United States registered from 2010 to 2020. One-year revision for PJI following pTKA with ALBC + SAP vs. PBC + SAP, and single vs. multiple SAP doses was compared. We computed cumulative percent revision (1 minus Kaplan-Meier) using distributed analysis method and adjusted hazard rate ratios (HRRs) using Cox regression analyses within each registry. Advanced distributed meta-analysis was performed to summarize HRRs from all countries. Results: Among all pTKAs, 64.4% were performed with ALBC + SAP. Each registry reported a 1-year cumulative percent revision for PJI of <1.00% for both pTKAs with ALBC + SAP (0.34%-0.80%) and with PBC + SAP (0.54%-0.69%). The distributed meta-analysis showed HRR = 1.21; (95% confidence interval [CI], 0.79-1.87) for ALBC + SAP compared with PBC + SAP. Similar risk of PJI revision was observed between pTKAs with ALBC + single vs. multiple doses of SAP: 2 doses (0.95; 95% CI, 0.68-1.33), 3 doses (1.09; 95% CI, 0.64-1.87), and 4 doses (1.23; 95% CI, 0.69-2.21). Comparable results were found for the PBC + SAP group except for higher risk of PJI revision with 4 doses of SAP (2.74; 95% CI, 1.11-6.75). Conclusions: ALBC and PBC entailed similar risk of PJI revision when patients received SAP in pTKA, regardless of number of SAP doses. ALBC or PBC used in combination with SAP in pTKAs, with one single preoperative dose of SAP may be sufficient without compromising the patient safety. Level of evidence: Level III. See Instructions for Authors for a complete description of levels of evidence.

Identifiers

PMID39664766
PMCPMC11623873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.